Biofilm maturity studies indicate sharp debridement opens a timedependent therapeutic window

Journal of Wound Care

Volumn 19, Issue 8, 2010, Pages 320-328

  Wolcott, R D ^a   Rumbaugh, K P ^b   James, G ^c   Schultz, G ^d   Phillips, P ^d   Yang, Q ^d   Waiters, C ^b   Stewart, P S ^c   Dowd, S E ^e,f  

^a Southwest Regional Wound Care Center Lubbock   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e Research and Testing Laboratory   (United States)

^f Medical Biofilm Research Institute Lubbock   (United States)

Author keywords

Clinical biofilms; In vitro biofilm sensitivity; Mouse surgical excision model; Porcine explants model

Indexed keywords

EID: 77958021478     PISSN: 09690700     EISSN: None     Source Type: Journal    
DOI: 10.12968/jowc.2010.19.8.77709     Document Type: Article

References (40)

1. Cardinal, M., Eisenbud, D. E., Armstrong, D. G. et al. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen 2009;17:3, 306-311.
2. Falanga, V., Brem, H., Ennis, W. J. et al. Maintenance debridement in the treatment of difficult-to-heal chronic wounds. Recommendations of an expert panel. Ostomy Wound Manage 2008; S2-S13.
3. Schultz, G. S., Sibbald, R. G., Falanga. V. et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen 2003;11(Suppl. 1), 1-28.
4. Wolcott, R. D., Kennedy, J. P., Dowd, S. E. Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J Wound Care 2009;18:2, 54-56.
5. Medicare. Trail Blazer Health Enterprises LCD Titled Wound Care. 1/3/08. Ref Type: Internet Communication
6. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen 2008;16(1):37-44.
7. Schaber, J. A., Triffo, W. J., Suh, S. J. et al. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun 2007;75:8, 3715-3721.
8. Harrison-Balestra, C., Cazzaniga, A. L, Davis, S. C., Mertz, P. M. A woundisolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg 2003;29:6, 631-635.
9. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001;358:9276, 135-138.
10. Stewart, P. S. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002;292:2, 107-113.
11. Russell AD. Mechanisms of bacterial insusceptibility to biocides. Am J Infect Control 2001;29:4, 259-261.
12. Stickler, D. J. Susceptibility of antibiotic-resistant gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. Symp Ser Soc Appl Microbiol 2002;31:163S-170S.
13. Leid, J. G., Willson, C. J., Shirtliff. M. E. et al. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gammamediated macrophage killing. J Immunol 2005;175:11, 7512-7518.
14. Leid, J. G., Shirtliff, M. E., Costerton, J. W., Stoodley, A. P. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002;70:11, 6339-6345.
15. Costerton, J. W., Geesey, G. G., Cheng, K. J. How bacteria stick. Sci Am 1978:238:1, 86-95.
16. Costerton, J. W. Introduction to biofilm. Int J Antimicrob Agents 1999;11:3-4, 217-221.
17. Davies, D. G., Parsek, M. R., Pearson, J. P. et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998;280:5361, 295-298.
18. Donlan, R. M, Costerton, J. W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:2, 167-193.
19. Hall-Stoodley, L., Costerton, J. W., Stoodley, P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004;2:2, 95-108.
20. Stewart, P. S., Franklin, M. J. Physiological heterogeneity in biofilms. Nat Rev Microbiol 2008;6:3, 199-210.
21. Fux, C. A., Costerton, J. W, Stewart, P. S., Stoodley, P. Survival strategies of infectious biofilms. Trends in Microbiology 2005;13:1, 34-40.
22. Allegrucci M, Hu FZ, Shen K, et al. Phenotypic characterization of Streptococcus pneumoniae biofilm development. J Bacteriol 2006;188(7):2325-35.
23. Ehrlich GD, Hu FZ, Shen K, Stoodley P, Post JC. Bacterial plurality as a general mechanism driving persistence in chronic infections. Clin Orthop Relat Res 2005; (437):20-4.
24. Ren, D, Bedzyk, L. A., Thomas, S. M. et al. Gene expression in Escherichia coli biofilms. AppI Microbiol Biotechnol 2004;64:4, 515-524.
25. Cho, K. H., Caparon, M. G. Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol 2005;57:6, 1545-1556.
26. Werner, E., Roe, F., Bugnicourt, A. et al. Stratified growth in Pseudomonas aeruginosa biofilms. AppI Environ Microbiol 2004;70:10, 6188-6196.
27. Rani, S. A., Pitts, B., Beyenal, H. et al. Spatial patterns of DNA replication, protein synthesis, and oxygen concentration within bacterial biofilms reveal diverse physiological slates. J Bacteriol 2007;189:11, 4223-4233.
28. Sauer, K., Camper, A. K., Ehrlich, G. D. et al. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 2002;184:1140.
29. Desrosiers, M., Myntti, M., James, G. Methods for removing bacterial biofilms: in vitro study using clinical chronic rhinosinusitis specimens. Am J Rhinol 2007;21:5, 527-532.
30. Schmook, F. R, Meingassner, J. G., Billich, A. Comparison of human skin or epidermis models with human and animal skin in in vitro percutaneous absorption. lntJ Pharm 2001;215:1-2, 51-56.
31. Brown, R. L., Greenhalgh, D. G. Mouse models to study wound closure and topical treatment of infected wounds in healingimpaired and normal healing hosts. Wound Repair Regen 1997;5:2, 198-204.
32. Rumbaugh, K. P, Diggle, S. P., Watters, C. M. et al. Quorum sensing and the social evolution of bacterial virulence. Curr Biol 2009;19:4, 341-345.
33. Holloway, B. W., Krishnapillai. V., Morgan, A. F. Chromosomal genetics of Pseudomonas. Microbiol Rev 1979;43:1, 73-102.
34. Wolcott, R. D., Gontcharova. V., Sun, Y, Dowd, S. E. Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and titanium amplicon pyrosequencing and metagenomic approaches. BMC Microbiol 2009;9:226.
35. Rose, H, Baldwin, A., Dowson, C. G., Mahenthiralingam, E. Biocide susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother 2009;63:3, 502-510.
36. Costerton, J. W., Stewart, P. S. Battling biofilms. Sci Am 2001;285:1, 74-81.
37. Stewart, P. S., Rayner, J., Roe, F., Rees. W. M. Biofilm penetration and disinfection efficacy of alkaline hypochlorite and chlorosulfamates. J Appl Microbiol 2001;91:3, 525-532.
38. Stewart, P. S., Davison, W. M., Steenbergen, J. N. Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 2009;53:8, 3505-3507.
39. Mah, T. F., O'Toole, G. A. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001;9:1, 34-39.
40. Stewart, P. S. Diffusion in biofilms. J Bacteriol 2003;185:5, 1485-1491.